首页> 外国专利> METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIBODIES

METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIBODIES

机译:血管内皮生长因子抗体的同种异体稀释解决血管内皮功能障碍的方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to experimental cardiology and pharmacology, and concerns correction of endothelial dysfunction. That is ensured by administering a mixture of solutions of homoeopathic dilutions of monoclonal antibodies to vascular endothelium growth factor (VEGF) intragastrically into Wistar white male rats 2 times a day in a dose of 4.5 mg/kg for 28 days with underlying intraperitoneal administration of L-NAME in a dose of 12.5 mg/kg a day.;EFFECT: administering homoeopathic dilutions of monoclonal antibodies to VEGF prevents developing L-NAME induced endothelial dysfunction.;1 tbl
机译:技术领域本发明涉及医学,即涉及实验性心脏病学和药理学,并且涉及对内皮功能障碍的矫正。通过向腹腔注射腹腔注射L的大鼠每天两次以4.5 mg / kg的剂量向Wistar雄性大鼠腹腔内注射Wistar雌性大鼠的抗血管内皮生长因子(VEGF)单克隆抗体的同种异体稀释液的混合物来确保28天-NAME的剂量为每天12.5 mg / kg。;效果:施用针对VEGF的单克隆抗体的顺势稀释液可防止发展为L-NAME诱导的内皮功能障碍。1tbl

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号